Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism
- 1 December 1993
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 44 (6) , 1259-1265
- https://doi.org/10.1038/ki.1993.377
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pharmacokinetics of Calcitriol in Continuous Ambulatory and Cycling Peritoneal Dialysis PatientsAmerican Journal of Kidney Diseases, 1990
- Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysisKidney International, 1989
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.Journal of Clinical Investigation, 1989
- Pharmacological Parathyroidectomy by Oral 1,25(OH)2D3 Pulse TherapyNephron, 1989
- Effect of Intravenous 1-Alpha-Hydroxyvitamin D3 on Secondary Hyperparathyroidism in Chronic Uremic Patients on Maintenance HemodialysisNephron, 1989
- Suppression of Serum Parathyroid Hormone Levels by Intravenous Alphacalcidol in Uremic Patients on Maintenance HemodialysisNephron, 1988
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984
- Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.BMJ, 1981
- 1,25 Dihydroxycholecalciferol Effects in Chronic DialysisAnnals of Internal Medicine, 1978